Cantor Raises Trulieve Cannabis Price Target On Latest Florida Numbers


20-Year Pro Trader Reveals His "MoneyLine"

Ditch your indicators and use the "MoneyLine". A simple line tells you when to buy and sell without the guesswork. It’s a line on a chart that’s helped Nic Chahine win 83% of his options buys. Here's how he does it.


The latest data from the Office of Medical Marijuana Use supports the thesis that Florida is one of America’s most vibrant medical markets and Trulieve Cannabis Corp. (OTC:TCNNF) enjoys a strong competitive position in this market, according to Cantor Fitzgerald.

The Trulieve Cannabis Analyst

Cantor’s Pablo Zuanic maintained an Overweight rating for Trulieve Cannabis, while raising the price target from $50 to $52.

The Trulieve Cannabis Thesis

Trulieve Cannabis has been gaining market share and its sales-per-store figures are meaningfully higher than peers, Zuanic said in the note.

Patient count in the Florida market has risen by 20% year to date, while flower volumes have surged 80% sequentially, the analyst mentioned. He added that volumes for other products like vapes, concentrates and topicals grew by 35% in the first half of the year.

Zuanic further noted that lifting the cap on stores and cultivation capacity will result in the largest companies strengthening their foothold in the market, as few have the size of investment required to tap on the opportunity.

The analyst expects Trulieve Cannabis to generate sales growth of 18% in the second quarter, beating the consensus estimate of 10%. He added that although a resurgence of Covid-19 infections represents a risk, the outbreak had not hurt sales in the first half of the year.

Price Action

Shares of Trulieve Cannabis had appreciated by 3% to $12.64 at the time of publication Tuesday.

Related Links:
Analyst Explains Why He's Bearish On Tilray And Aurora Cannabis, Recommends MSOs
Cannabis Countdown: Top 10 Marijuana And Psychedelic Stock News Stories Of The Week


20-Year Pro Trader Reveals His "MoneyLine"

Ditch your indicators and use the "MoneyLine". A simple line tells you when to buy and sell without the guesswork. It’s a line on a chart that’s helped Nic Chahine win 83% of his options buys. Here's how he does it.


ENTER TO WIN $500 IN STOCK OR CRYPTO

Enter your email and you'll also get Benzinga's ultimate morning update AND a free $30 gift card and more!

Posted In: Analyst ColorPrice TargetReiterationAnalyst RatingsCantor FitzgeraldCovid-19Pablo Zuanic